Paclitaxel and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Paclitaxel (paclitaxel), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Carboplatin, and have Resorption bone increased.

The phase IV clinical study analyzes which people have Hepatitis c when taking Paclitaxel. It is created by eHealthMe based on reports of 85,850 people who have side effects when taking Paclitaxel from the FDA, and is updated regularly.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

What is Hepatitis c?

Hepatitis c is found to be associated with 785 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On Apr, 30, 2026

85,850 people reported to have side effects when taking Paclitaxel.
Among them, 22 people (0.03%) have Hepatitis c.

Among these 22 people:

How long have people been on Paclitaxel when they have Hepatitis c? *

What is the gender of people who have Hepatitis c when taking Paclitaxel? *

female: 75 %
male: 25 %

What is the age of people who have Hepatitis c when taking Paclitaxel? *

What are other drugs people take besides Paclitaxel? *

What are other side effects people have besides Hepatitis c? *

Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 9 people, 40.91%
Splenomegaly (enlargement of spleen): 9 people, 40.91%
Metastases To Bone (cancer spreads to bone): 8 people, 36.36%
Renal Cyst (kidney cyst): 8 people, 36.36%
Metastases To Lung (cancer spreads to lung): 8 people, 36.36%
Oedema (fluid collection in tissue): 8 people, 36.36%
Metastases To Liver (cancer spreads to liver): 8 people, 36.36%
Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 36.36%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 36.36%
Pain: 8 people, 36.36%

What are the existing conditions these people have? *

Resorption Bone Increased: 8 people, 36.36%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 22.73%
Pain: 1 person, 4.55%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 4.55%
Neuralgia (pain in one or more nerves): 1 person, 4.55%
Nausea (feeling of having an urge to vomit): 1 person, 4.55%
Metastases To Bone (cancer spreads to bone): 1 person, 4.55%
Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 4.55%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 4.55%
Breast Cancer Stage I: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Paclitaxel and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paclitaxel:

Paclitaxel (85,928 reports)

Hepatitis c treatments and more:

Hepatitis c (131,813 reports)

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Hepatitis c (785 drugs)

Browse all the conditions that are associated with Hepatitis c:

Hepatitis c (984 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Paclitaxel) and Paclitaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.